Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2024-02-08 | 2023-11-28 |
| Drug Identification Number | 02230733 | 02230733 |
| Brand name | TRINIPATCH 0.4 | TRINIPATCH 0.4 |
| Common or Proper name | Trinipatch 0.4 mg | Trinipatch 0.4 mg |
| Company Name | PALADIN PHARMA INC. | PALADIN PHARMA INC. |
| Ingredients | NITROGLYCERIN | NITROGLYCERIN |
| Strength(s) | 0.4MG | 0.4MG |
| Dosage form(s) | PATCH | PATCH |
| Route of administration | TRANSDERMAL TRANSDERMAL | TRANSDERMAL TRANSDERMAL |
| Packaging size | 30 patches and 100 patches | 30 patches and 100 patches |
| ATC code | C01DA | C01DA |
| ATC description | VASODILATORS USED IN CARDIAC DISEASES | VASODILATORS USED IN CARDIAC DISEASES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2023-11-28 | 2023-11-28 |
| Estimated end date | 2024-03-01 | 2023-12-18 |
| Actual end date | 2024-02-07 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Release process delays | Release process delays |
| Health Canada comments |